Inventor · disambiguated record
Jack A. Schalken
Also filed as: SCHALKEN JACK A
9 granted patents·13 pending applications·109 citations·filing 2001–2023
88Inventor score
Files withSTICHTING KATHOLIEKE UNIV6MDXHEALTH RES B V3HESSELS DAPHNE2MDXHEALTH SA2SMIT FRANCISCUS PETRUS2
Top patents by PatentIndex Score
22 records- 0195US7138235B2Nucleic acid molecules comprising the promoter for PCA3, and uses thereofSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Nov 21, 2006·43 cites·16 claims
- 0292US7960109B2mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancerSTICHTING KATHOLIEKE UNIV·Filed 2005·Granted Jun 14, 2011·20 cites·22 claims
- 0387US6897024B2Nucleic acid molecules comprising the promoter for PCA3, and uses thereofSTICHTING KATHOLIEKE UNIV·Filed 2001·Granted May 24, 2005·32 cites·15 claims
- 0486US8257924B2mRNA ratios in urinary sediments and/or urine as a prognostic and/or theranostic marker for prostate cancerHESSELS DAPHNE·Filed 2011·Granted Sep 4, 2012·8 cites·22 claims
- 0583US9096907B2Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV·Filed 2013·Granted Aug 4, 2015·3 cites·21 claims
- 0681US9951390B2Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV THE UNIV MEDICAL CENTRE NIJMEGEN·Filed 2016·Granted Apr 24, 2018·2 cites·20 claims
- 0778US10752957B2Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIVERSITEIT THE UNIV MEDICAL CENTRE NIJMEGEN·Filed 2018·Granted Aug 25, 2020·1 cites·19 claims
- 0873US2024076743A1Method for Predicting and Treating Clinically Significant Prostate CancerMDXHEALTH SA·Filed 2023·Application pending·0 cites
- 0967US11767563B2Method for predicting and treating clinically significant prostate cancerMDXHEALTH SA·Filed 2019·Granted Sep 26, 2023·0 cites·10 claims
- 1067US2020392588A1Prostate Cancer Prognostic Compositions and KitsSTICHTING KATHOLIEKE UNIV THE UNIV MEDICAL CENTRE NIJMEGEN·Filed 2020·Application pending·0 cites
- 1165US2009233285A1Specific method of prostate cancer detection based on pca3 gene, and kits thereforSTICHTING KATHOLIEKE UNIV·Filed 2008·Application pending·0 cites
- 1260US2015307948A1Prostate cancer prognostic compositions and kitsSTICHTING KATHOLIEKE UNIV·Filed 2015·Application pending·0 cites
- 1359US2005164223A1Specific method of prostate cancer detection based on PCA3 gene and kits thereforUNIV MEDICAL CT NIJMEGEN·Filed 2004·Application pending·0 cites
- 1457US2021246515A1COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCERMDXHEALTH RES B V·Filed 2021·Application pending·0 cites
- 1557US2020165684A1COMBINATION OF mRNA EXPRESSION LEVELS OF DLX1 AND HOXC6 IN URINE AS MOLECULAR MARKERS IN PROSTATE CANCERMDXHEALTH RES B V·Filed 2019·Application pending·0 cites
- 1656US2012309006A1Specific method of prostate cancer detection based on pca3 gene, and kits thereforSCHALKEN JACK A·Filed 2012·Application pending·0 cites
- 1754US2012309007A1Prostate cancer prognostic compositions and kitsHESSELS DAPHNE·Filed 2012·Application pending·0 cites
- 1853US10329625B2Method for detecting DLX1 mRNA, HOXC6 mRNA, and KLK3 mRNA in a urine sample and predicting and treating clinically significant prostate cancerMDXHEALTH RES B V·Filed 2016·Granted Jun 25, 2019·0 cites·8 claims
- 1953US2012108453A1Molecular markers in prostate cancerSMIT FRANCISCUS PETRUS·Filed 2009·Application pending·0 cites
- 2045US2011165178A1Diagnosis of prostate cancerCENTRE NAT RECH SCIENT·Filed 2008·Application pending·0 cites
- 2141US2015017640A1Combinations of Molecular Markers in Prostate Cancer providing a Diagnostic Tool with Improved Sensitivity/SpecificityNOVIOGENDIX RES B V·Filed 2012·Application pending·0 cites
- 2233US2012142553A1Molecular Markers in Kidney CancerSMIT FRANCISCUS PETRUS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jack A. Schalken files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →